666

RBC BIOSCIENCE CORPORATION

No trades
See on Supercharts
Market capitalization
‪264.70 M‬TWD
1.35TWD
‪6.43 M‬TWD
‪172.47 M‬TWD
Beta (1Y)
0.43
Employees (FY)
53
Revenue / Employee (1Y)
‪106.00 K‬TWD
Net income / Employee (1Y)
‪3.95 K‬TWD

About RBC BIOSCIENCE CORPORATION


CEO
Ming Wei Zhuo
Headquarters
New TaiPei
Founded
2006
ISIN
TW0006848005
FIGI
BBG0132GD3Q5
RBC Bioscience Corp. manufactures reagents and devices for life science and molecular diagnosis. Its products include real genomics, MagCore automated nudeic acid extractor and nudeic acid extraction kits, HIT competent cells, polymerases, cloning systems and DNA ladders. The company was founded on February 7, 2006 and is headquartered in New Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6848 is 20.55 TWD — it has increased by 0.74% in the past 24 hours. Watch RBC BIOSCIENCE CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange RBC BIOSCIENCE CORPORATION stocks are traded under the ticker 6848.
6848 stock hasn't changed in a week, the month change is a −13.66% fall, over the last year RBC BIOSCIENCE CORPORATION has showed a 43.21% increase.
6848 reached its all-time high on Oct 25, 2021 with the price of 56.00 TWD, and its all-time low was 13.45 TWD and was reached on Feb 9, 2023. View more price dynamics on 6848 chart.
See other stocks reaching their highest and lowest prices.
6848 stock is 0.73% volatile and has beta coefficient of 0.43. Track RBC BIOSCIENCE CORPORATION stock price on the chart and check out the list of the most volatile stocks — is RBC BIOSCIENCE CORPORATION there?
Yes, you can track RBC BIOSCIENCE CORPORATION financials in yearly and quarterly reports right on TradingView.
6848 net income for the last half-year is ‪13.14 M‬ TWD, while the previous report showed ‪4.12 M‬ TWD of net income which accounts for 218.72% change. Track more RBC BIOSCIENCE CORPORATION financial stats to get the full picture.
RBC BIOSCIENCE CORPORATION dividend yield was 2.72% in 2023, and payout ratio reached 88.80%. The year before the numbers were 7.07% and 384.62% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 14, 2024, the company has 53.00 employees. See our rating of the largest employees — is RBC BIOSCIENCE CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RBC BIOSCIENCE CORPORATION EBITDA is ‪47.61 M‬ TWD, and current EBITDA margin is 19.26%. See more stats in RBC BIOSCIENCE CORPORATION financial statements.
Like other stocks, 6848 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RBC BIOSCIENCE CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RBC BIOSCIENCE CORPORATION technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RBC BIOSCIENCE CORPORATION stock shows the buy signal. See more of RBC BIOSCIENCE CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.